Sepsis Diagnostics Market
PUBLISHED: 2023 ID: SMRC22892
SHARE
SHARE

Sepsis Diagnostics Market

Sepsis Diagnostics Market Forecasts to 2028 - Global Analysis By Test Type (Laboratory Tests, Point-of-Care Tests and Other Test Types), By Pathogen (Bacterial Sepsis, Viral Sepsis, Fungal Sepsis and Other Pathogens), By Method, By Product, By Technology, By End User and By Geography

4.3 (57 reviews)
4.3 (57 reviews)
Published: 2023 ID: SMRC22892

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2020-2028

Estimated Year Value (2022)

US $686.7 MN

Projected Year Value (2028)

US $1326.8 MN

CAGR (2022 - 2028)

11.6%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Sepsis Diagnostics Market is accounted for $686.7 million in 2022 and is expected to reach $1,326.8 million by 2028 growing at a CAGR of 11.6% during the forecast period. When the immune system of the body assaults its own tissues in response to an infection, sepsis, a potentially lethal condition, develops. Organs perform badly and inappropriately when the body's infection-fighting mechanisms are activated. Sepsis can lead to septic shock. This unexpected drop in blood pressure can seriously harm organs and even result in death. The likelihood of survival is improved by receiving intravenous fluids and antibiotics as soon as feasible.

According to the Global Sepsis Alliance in April 2020, around 30% of COVID-19 patients had evidence of liver injury and around 75% reported a depressed immune response in Seattle, U.S.



Market Dynamics:

Driver:

Rising incidence of hospital-acquired infections

Nosocomial infections, sometimes referred to as hospital-acquired infections or HAIs, are a leading global cause of morbidity and mortality. Urinary tract infections, pneumonia, and sepsis are the most typical hospital acquired infections (HAIs). In immune compromised individuals, geriatric patients, and people with chronic conditions, HAIs can result in sepsis. In the coming years, there will be an increase in need for appropriate sepsis diagnostic devices due to the worldwide rapid increase in HAIs. As a result, it is anticipated that the market for sepsis diagnostics would rise as a result of the increasing prevalence of hospital-acquired illnesses.

Restraint:

High cost of automated diagnostic devices

When compared to blood culture tests, which can be purchased for as little as USD 28–35, the price of molecular diagnostic testing is between $300 and $3,000, which is extremely exorbitant. Due to tight finances, government hospitals (particularly in developing countries) and academic research labs are unable to purchase the automated diagnostic gadgets that companies are concentrating on developing for identifying sepsis. These devices are based on advanced technology, such as molecular diagnostics. Moreover, it is increasingly the main obstacle to market expansion.

Opportunity:

Evolution of novel biomarkers for sepsis diagnosis

Even with the present availability of extended-spectrum antibiotics and cutting-edge medical care, sepsis remains one of the major causes of mortality and morbidity. In order to facilitate early diagnosis, identify patient populations at high risk of complications, and track the course of the disease, which are vital measures for effective therapy and bettering patient outcomes, biomarkers offer a tool. Additionally, the introduction of efficient treatments and ongoing clinical trials will create favourable chances for the sepsis diagnostics market during the anticipated time frame.

Threat:

Shortage of skilled healthcare professionals

Sepsis is a potentially fatal condition that requires prompt diagnosis and treatment from trained medical personnel. Only 50% of patients with severe sepsis conveyed by the EMS system had a paramedic, which raises serious concerns about the global talent deficit. Each stage of patient treatment is impacted by a shortage of qualified paramedics, including sepsis awareness, sepsis screening, and making an accurate diagnosis.

Covid-19 Impact

Diagnostics for sepsis sales increased as a result of the COVID-19 epidemic. Sepsis detection tools, reagents, and test kits are expected to be more quickly adopted as a result of the COVID-19 pandemic's rapid global spread and the rise of sepsis cases among COVID-19 patients. As older people are more susceptible to complications like acute respiratory distress syndrome (ARDS), which is typically brought on by pneumonia and increases the risk of sepsis, the current worldwide crisis has drawn attention to the hazards that older people confront. The need for early sepsis diagnosis in patients with COVID-19 infections is therefore increased.

The molecular diagnostics segment is expected to be the largest during the forecast period

The molecular diagnostics segment is estimated to have a lucrative growth, due to the adoption of molecular diagnostic technology because of its many benefits, including high sensitivity, accuracy, and quick turnaround times compared to other technologies. This technique's drawback is that it is unable to detect organisms that are impossible to cultivate. Nevertheless, following blood culture, the molecular diagnostics method is regarded as a standard method for identifying pathogens. The more sensitive, specific, and expedient nature of molecular diagnostic solutions is anticipated to drive the segment's expansion over the course of the forecast period.

The laboratory tests segment is expected to have the highest CAGR during the forecast period

The laboratory tests segment is anticipated to witness the highest CAGR growth during the forecast period, due to the fact that when identifying sepsis, lab testing is more accurate than POC testing. Hospital acquired infections (HAIs) are on the rise among hospitalised patients, and healthcare infrastructure improvements, particularly in developing nations, are expected to help the laboratory testing market grow. The segment is expanding in part due to the fact that most diagnoses are made in labs.

Region with largest share:

North America is projected to hold the largest market share during the forecast period, attributed to the region's increased use of modern diagnostic technologies as a result of the presence of an established healthcare infrastructure. Additionally, the market expansion in this area is being fuelled by the substantial presence of important competitors and a favourable reimbursement system. Moreover, it is anticipated that the rising prevalence of infectious illnesses and sepsis will increase need for cutting-edge diagnostic methods.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. It is projected that the rapid technological advancements and rising public awareness will drive market expansion. Additionally, there is an increasing demand for Sepsis diagnostic tools in countries with a high frequency of infectious diseases. A rise in regional and worldwide players' efforts to permit coverage of cutting-edge scientific robotic technology is another factor contributing to this region's profitable expansion.



Key players in the market

Some of the key players profiled in the Sepsis Diagnostics Market include Abbott Laboratories Inc., Amara Health Analytics, Beckman Coulter, Inc, Becton, Dickinson and Company (BD), Bruker Corporation, Cerner Corporation, Cube Dx GmbH, Danaher Corporation, EKF Diagnostics, Epic Systems Corporation, GE Healthcare, Koninklijke Philips N.V., Luminex Corporation, McKesson Corporation, Response Biomedical Corp., T2 Biosystems Inc. and Thermo Fisher Scientific, Inc.

Key Developments:

In December 2021, Immunoexpress received the United States Food and Drug Administration (FDA) approval for SeptiCyte RAPID.

In October 2021, Prenosis Inc., a precision diagnostics firm that uses artificial intelligence to enhance clinical diagnosis, expanded its existing agreement with Roche Diagnostics to improve and speed the clinical detection of sepsis.

In May 2020, Beckman Coulter announced the availability of its DxH 690T hematology analyzer in the U.S. which is used as the early sepsis indicator. This announcement has helped company to increase its global presence and growth in the revenue as well.

Test Types Covered:
• Laboratory Tests
• Point-of-Care Tests
• Other Test Types

Pathogens Covered:
• Bacterial Sepsis
• Viral Sepsis
• Fungal Sepsis
• Other Pathogens

Methods Covered:
• Conventional Diagnostics
• Automated Diagnostics
• Other Methods

Products Covered:
• Software
• Instruments
• Assays & Reagents
• Blood Culture Media
• Other Products

Technologies Covered:
• Biomarkers
• Microfluidics
• Flow Cytometry
• Molecular Diagnostics
• Immunoassays
• Microbiology
• DNA Microarrays
• Syndromic Panel testing
• Other Technologies

End Users Covered:
• Research Laboratories & Academic Institutes
• Pathology & Reference Laboratories
• Hospitals and Specialty Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Sepsis Diagnostics Market, By Test Type
5.1 Introduction
5.2 Laboratory Tests
5.3 Point-of-Care Tests
5.4 Other Test Types

6 Global Sepsis Diagnostics Market, By Pathogen
6.1 Introduction
6.2 Bacterial Sepsis
6.2.1 Gram-Positive Bacterial Sepsis
6.2.2 Gram-Negative Bacterial Sepsis
6.3 Viral Sepsis
6.4 Fungal Sepsis
6.5 Other Pathogens

7 Global Sepsis Diagnostics Market, By Method
7.1 Introduction
7.2 Conventional Diagnostics
7.3 Automated Diagnostics
7.4 Other Methods

8 Global Sepsis Diagnostics Market, By Product
8.1 Introduction
8.2 Software
8.3 Instruments
8.4 Assays & Reagents
8.5 Blood Culture Media
8.6 Other Products

9 Global Sepsis Diagnostics Market, By Technology
9.1 Introduction
9.2 Biomarkers
9.3 Microfluidics
9.4 Flow Cytometry
9.5 Molecular Diagnostics
9.5.1 Syndromic Panel-Based Testing
9.5.2 DNA Sequencing
9.5.3 Microarrays
9.5.4 Peptide Nucleic Acid-Fluorescent In Situ Hybridization
9.5.5 PCR
9.6 Immunoassays
9.7 Microbiology
9.8 DNA Microarrays
9.9 Syndromic Panel testing
9.10 Other Technologies

10 Global Sepsis Diagnostics Market, By End User
10.1 Introduction
10.2 Research Laboratories & Academic Institutes
10.3 Pathology & Reference Laboratories
10.4 Hospitals and Specialty Clinics
10.5 Other End Users

11 Global Sepsis Diagnostics Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Abbott Laboratories Inc.
13.2 Amara Health Analytics
13.3 Beckman Coulter, Inc
13.4 Becton, Dickinson and Company (BD)
13.5 Bruker Corporation
13.6 Cerner Corporation
13.7 Cube Dx GmbH
13.8 Danaher Corporation
13.9 EKF Diagnostics
13.10 Epic Systems Corporation
13.11 GE Healthcare
13.12 Koninklijke Philips N.V.
13.13 Luminex Corporation
13.14 McKesson Corporation
13.15 Response Biomedical Corp.
13.16 T2 Biosystems Inc.
13.17 Thermo Fisher Scientific, Inc.

List of Tables
1 Global Sepsis Diagnostics Market Outlook, By Region (2020-2028) ($MN)
2 Global Sepsis Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
3 Global Sepsis Diagnostics Market Outlook, By Laboratory Tests (2020-2028) ($MN)
4 Global Sepsis Diagnostics Market Outlook, By Point-of-Care Tests (2020-2028) ($MN)
5 Global Sepsis Diagnostics Market Outlook, By Other Test Types (2020-2028) ($MN)
6 Global Sepsis Diagnostics Market Outlook, By Pathogen (2020-2028) ($MN)
7 Global Sepsis Diagnostics Market Outlook, By Bacterial Sepsis (2020-2028) ($MN)
8 Global Sepsis Diagnostics Market Outlook, By Gram-Positive Bacterial Sepsis (2020-2028) ($MN)
9 Global Sepsis Diagnostics Market Outlook, By Gram-Negative Bacterial Sepsis (2020-2028) ($MN)
10 Global Sepsis Diagnostics Market Outlook, By Viral Sepsis (2020-2028) ($MN)
11 Global Sepsis Diagnostics Market Outlook, By Fungal Sepsis (2020-2028) ($MN)
12 Global Sepsis Diagnostics Market Outlook, By Other Pathogens (2020-2028) ($MN)
13 Global Sepsis Diagnostics Market Outlook, By Method (2020-2028) ($MN)
14 Global Sepsis Diagnostics Market Outlook, By Conventional Diagnostics (2020-2028) ($MN)
15 Global Sepsis Diagnostics Market Outlook, By Automated Diagnostics (2020-2028) ($MN)
16 Global Sepsis Diagnostics Market Outlook, By Other Methods (2020-2028) ($MN)
17 Global Sepsis Diagnostics Market Outlook, By Product (2020-2028) ($MN)
18 Global Sepsis Diagnostics Market Outlook, By Software (2020-2028) ($MN)
19 Global Sepsis Diagnostics Market Outlook, By Instruments (2020-2028) ($MN)
20 Global Sepsis Diagnostics Market Outlook, By Assays & Reagents (2020-2028) ($MN)
21 Global Sepsis Diagnostics Market Outlook, By Blood Culture Media (2020-2028) ($MN)
22 Global Sepsis Diagnostics Market Outlook, By Other Products (2020-2028) ($MN)
23 Global Sepsis Diagnostics Market Outlook, By Technology (2020-2028) ($MN)
24 Global Sepsis Diagnostics Market Outlook, By Biomarkers (2020-2028) ($MN)
25 Global Sepsis Diagnostics Market Outlook, By Microfluidics (2020-2028) ($MN)
26 Global Sepsis Diagnostics Market Outlook, By Flow Cytometry (2020-2028) ($MN)
27 Global Sepsis Diagnostics Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
28 Global Sepsis Diagnostics Market Outlook, By Syndromic Panel-Based Testing (2020-2028) ($MN)
29 Global Sepsis Diagnostics Market Outlook, By DNA Sequencing (2020-2028) ($MN)
30 Global Sepsis Diagnostics Market Outlook, By Microarrays (2020-2028) ($MN)
31 Global Sepsis Diagnostics Market Outlook, By Peptide Nucleic Acid-Fluorescent In Situ Hybridization (2020-2028) ($MN)
32 Global Sepsis Diagnostics Market Outlook, By PCR (2020-2028) ($MN)
33 Global Sepsis Diagnostics Market Outlook, By Immunoassays (2020-2028) ($MN)
34 Global Sepsis Diagnostics Market Outlook, By Microbiology (2020-2028) ($MN)
35 Global Sepsis Diagnostics Market Outlook, By DNA Microarrays (2020-2028) ($MN)
36 Global Sepsis Diagnostics Market Outlook, By Syndromic Panel testing (2020-2028) ($MN)
37 Global Sepsis Diagnostics Market Outlook, By Other Technologies (2020-2028) ($MN)
38 Global Sepsis Diagnostics Market Outlook, By End User (2020-2028) ($MN)
39 Global Sepsis Diagnostics Market Outlook, By Research Laboratories & Academic Institutes (2020-2028) ($MN)
40 Global Sepsis Diagnostics Market Outlook, By Pathology & Reference Laboratories (2020-2028) ($MN)
41 Global Sepsis Diagnostics Market Outlook, By Hospitals and Specialty Clinics (2020-2028) ($MN)
42 Global Sepsis Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials